A prospective cohort study assessing the efficacy of Sofosbuvir/Velpatasvir in hepatitis C virus infected patients in France for 12 weeks by specialists or non-specialists
Latest Information Update: 29 Dec 2023
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms Helios 3
Most Recent Events
- 14 Nov 2023 Results of final analysis presented at The Liver Meeting 2023: 74th Annual Meeting of the American Association for the Study of Liver Diseases
- 08 Nov 2022 Interim results presented at The Liver Meeting 2022: 73rd Annual Meeting of the American Association for the Study of Liver Diseases
- 13 Jan 2022 New trial record